ABEONA THERAPEUTICS INC. Cost of Revenue
ABEONA THERAPEUTICS INC. (ABEO) reported Cost of Revenue of $4.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. cost of goods and services sold for the quarter ending 2026-06-30 was $4.18M.
- ABEONA THERAPEUTICS INC. cost of goods and services sold for the quarter ending 2026-03-31 was $2.70M.
- ABEONA THERAPEUTICS INC. cost of goods and services sold for the quarter ending 2025-12-31 was $1.04M.
- ABEONA THERAPEUTICS INC. cost of goods and services sold for the quarter ending 2025-09-30 was $488.00K.
- ABEONA THERAPEUTICS INC. cost of goods and services sold for fiscal 2025 was $1.53M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.18M 10-Q · filed 2026-08-13 | $6.87M 10-Q · filed 2026-08-13 | $7.92M derived: sum of 3 quarters · filed 2026-08-13 | $8.40M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $2.70M 10-Q · filed 2026-05-13 | $3.74M derived: sum of 2 quarters · filed 2026-05-13 | $4.23M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2025-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $1.53M derived: sum of 2 quarters · filed 2026-03-17 | $1.53M 10-K · filed 2026-03-17 | |
| 2025-09-30 | $488.00K 10-Q · filed 2025-11-12 | $488.00K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |